Governance Cosmos Health Inc.

COSM

US2214133058

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 18:07:52 05/03/2026 GMT			5-day change	1st Jan Change
0.3680 ^USD	-4.81%		-6.39%	-26.71%

02-24	Cosmos Health Inc. Appoints Dr. Dimitrios Iliopoulos to Advisory Board	CI
02-19	Cosmos Health Evaluates Strategic Monetization Options to Unlock Shareholder Value	CI

Executive Committee: Cosmos Health Inc.

Manager

Positions heldSince

Grigorios Siokas

60 year

Chief Executive Officer

25/02/2016

Demetrios Demetriades

59 year

Corporate Secretary

12/01/2014

George Terzis

44 year

Director of Finance/CFO

10/11/2020

Nikolaos Bardakis

Chief Operating Officer

31/01/2023

Composition of the Board of Directors: Cosmos Health Inc.

Director

CommitteesSince

Grigorios Siokas

60 year

Governance Committee
Nominating Committee

John Hoidas

60 year

Audit Committee	17/11/2016
Compensation Committee

Anastasios Aslidis

66 year

Compensation Committee
Audit Committee Chair	27/04/2022

Demetrios Demetriades

59 year

Audit Committee

12/01/2014

Suhel Bhutawala

47 year

Director/Board Member

17/09/2023

Manfred Ziegler

65 year

Director/Board Member	01/12/2022
Independent Dir/Board Member	01/12/2022

Latest Appointments: Cosmos Health Inc.

02-24	Cosmos Health Inc. Appoints Dr. Dimitrios Iliopoulos to Advisory Board	CI
01/10/25	Cosmos Health Inc. Appoints Theodoros C. Karkantzos as Member of Board, Effective September 30, 2025	CI
26/12/24	Cosmos Health Inc. Appoints Dimitrios Trafalis as Head of Oncology at the Company's Research and Development division	CI
22/09/23	Cosmos Health Inc. Announces Executive and Board Changes	CI
01/02/23	Cosmos Health Inc. Appoints Nikos Bardakis as Chief Operating Officer	CI
08/07/22	Cosmos Holdings, Inc. Appoints Dr. Panagiotis Zoumpoulakis to its Advisory Board	CI
28/04/22	Cosmos Holdings Inc. Announces Board and Committee Changes	CI

More news

Former Officers and Directors: Cosmos Health Inc.

Insider

Positions held

SinceUntil

Pavlos Ignatiades

Director/Board Member	10/11/2020	-
Chief Operating Officer	10/11/2020	31/01/2023
Public Communications Contact	31/01/2023	19/09/2023

Peter Goldstein

Director/Board Member	14/10/2020	27/04/2022
Independent Dir/Board Member	14/10/2020	27/04/2022

David Lowenstein

Director/Board Member

01/11/2020

Dimitrios Goulielmos

Comptroller/Controller/Auditor	18/05/2015	25/02/2016
Director/Board Member	26/09/2013	-
Chief Executive Officer	26/09/2013	25/02/2016
Chairman	26/09/2013	25/02/2016
Director of Finance/CFO	26/09/2013	25/02/2016
Independent Dir/Board Member	25/02/2016	-
President	18/02/2014	25/02/2016

Konstantinos Vassilopoulos

Chief Administrative Officer	-	-
Director/Board Member	04/01/2013	-
Investor Relations Contact	-	-
Corporate Officer/Principal	-	-
Corporate Secretary	04/01/2013	-

Panagiotis Drakopoulos

Director/Board Member	20/07/2009	-
Director of Finance/CFO	20/07/2009	-
Treasurer	20/07/2009	12/01/2014

Age distribution of managers

Parity Men Women

Male	8
Female	0

Of which Executive Committee

Male	4
Female	0

Of which Directors

Male	6
Female	0

Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. It offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. It is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.

Employees

149

Sector

Pharmaceuticals

More about the company